TBCA
gene geneOn this page
Summary
TBCA (tubulin folding cofactor A, HGNC:11579) is a protein-coding gene on chromosome 5q14.1, encoding Tubulin-specific chaperone A (O75347). Tubulin-folding protein; involved in the early step of the tubulin folding pathway. It is a common-essential gene (DepMap: required in 92.5% of cancer cell lines).
The product of this gene is one of four proteins (cofactors A, D, E, and C) involved in the pathway leading to correctly folded beta-tubulin from folding intermediates. Cofactors A and D are believed to play a role in capturing and stabilizing beta-tubulin intermediates in a quasi-native confirmation. Cofactor E binds to the cofactor D/beta-tubulin complex; interaction with cofactor C then causes the release of beta-tubulin polypeptides that are committed to the native state. This gene encodes chaperonin cofactor A. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene.
Source: NCBI Gene 6902 — RefSeq curated summary.
At a glance
- GWAS associations: 10
- Clinical variants (ClinVar): 14 total
- Druggable target: yes
- Cancer dependency (DepMap): dependent in 92.5% of screened cell lines (common-essential)
- MANE Select transcript:
NM_004607
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:11579 |
| Approved symbol | TBCA |
| Name | tubulin folding cofactor A |
| Location | 5q14.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000171530 |
| Ensembl biotype | protein_coding |
| OMIM | 610058 |
| Entrez | 6902 |
Gene structure
Transcript identifiers
Ensembl transcripts: 13 — 11 protein_coding, 1 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000306388, ENST00000380377, ENST00000517679, ENST00000517881, ENST00000518218, ENST00000518338, ENST00000520039, ENST00000520361, ENST00000522370, ENST00000651106, ENST00000932727, ENST00000932728, ENST00000932729
RefSeq mRNA: 3 — MANE Select: NM_004607
NM_001297738, NM_001297740, NM_004607
CCDS: CCDS4040, CCDS75263, CCDS78024
Canonical transcript exons
ENST00000380377 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001484695 | 77776205 | 77776339 |
| ENSE00002120354 | 77691166 | 77691498 |
| ENSE00003510631 | 77693266 | 77693352 |
| ENSE00003684976 | 77708242 | 77708347 |
Expression profiles
Bgee: expression breadth ubiquitous, 180 present calls, max score 99.27.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 194.6560 / max 2017.0104, expressed in 1828 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 62193 | 116.5473 | 1827 |
| 62192 | 78.0838 | 1812 |
| 62194 | 0.0249 | 2 |
Top tissues by expression
257 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right adrenal gland cortex | UBERON:0035827 | 99.27 | gold quality |
| left adrenal gland | UBERON:0001234 | 99.24 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 99.23 | gold quality |
| right adrenal gland | UBERON:0001233 | 99.22 | gold quality |
| ganglionic eminence | UBERON:0004023 | 99.22 | gold quality |
| cortical plate | UBERON:0005343 | 99.21 | gold quality |
| adrenal tissue | UBERON:0018303 | 99.21 | gold quality |
| ventricular zone | UBERON:0003053 | 99.06 | gold quality |
| islet of Langerhans | UBERON:0000006 | 98.94 | gold quality |
| left ovary | UBERON:0002119 | 98.94 | gold quality |
| adenohypophysis | UBERON:0002196 | 98.93 | gold quality |
| mucosa of stomach | UBERON:0001199 | 98.89 | gold quality |
| popliteal artery | UBERON:0002250 | 98.80 | gold quality |
| tibial artery | UBERON:0007610 | 98.80 | gold quality |
| right ovary | UBERON:0002118 | 98.78 | gold quality |
| right uterine tube | UBERON:0001302 | 98.76 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 98.72 | gold quality |
| metanephros cortex | UBERON:0010533 | 98.72 | gold quality |
| body of stomach | UBERON:0001161 | 98.71 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 98.71 | gold quality |
| endocervix | UBERON:0000458 | 98.70 | gold quality |
| right lung | UBERON:0002167 | 98.70 | gold quality |
| left coronary artery | UBERON:0001626 | 98.66 | gold quality |
| body of uterus | UBERON:0009853 | 98.66 | gold quality |
| left uterine tube | UBERON:0001303 | 98.63 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 98.63 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 98.62 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 98.59 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 98.56 | gold quality |
| lower esophagus | UBERON:0013473 | 98.53 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-8894 | yes | 1597.85 |
| E-ANND-3 | yes | 13.17 |
| E-MTAB-10042 | yes | 8.66 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
20 targeting TBCA, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-379-3P | 99.69 | 69.60 | 1524 |
| HSA-MIR-411-3P | 99.69 | 69.63 | 1524 |
| HSA-MIR-4519 | 99.48 | 66.10 | 859 |
| HSA-MIR-6507-3P | 99.35 | 67.32 | 1059 |
| HSA-MIR-488-5P | 99.28 | 68.12 | 821 |
| HSA-MIR-580-5P | 99.28 | 70.94 | 1776 |
| HSA-MIR-4705 | 99.10 | 69.10 | 1091 |
| HSA-MIR-548L | 99.06 | 70.90 | 2560 |
| HSA-MIR-12135 | 98.99 | 70.26 | 1814 |
| HSA-MIR-508-3P | 98.66 | 69.62 | 887 |
| HSA-MIR-203B-5P | 97.24 | 68.54 | 543 |
| HSA-MIR-6718-5P | 97.24 | 68.15 | 553 |
| HSA-MIR-711 | 96.60 | 65.75 | 528 |
| HSA-MIR-514A-3P | 96.43 | 67.77 | 1048 |
| HSA-MIR-514B-3P | 96.43 | 67.77 | 1048 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 92.5% of screened cell lines, common-essential.
Literature-anchored findings (GeneRIF, showing 2)
- TBCA is essential for cell viability and its knockdown produces a decrease in the amount of soluble tubulin, modifications in microtubules and G1 cell cycle arrest. (PMID:15963512)
- overexpression of TBCA did not induce biocharacteristics that directly contrasted to those of TBCA knockdown (PMID:23740643)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tbca | ENSDARG00000016754 |
| mus_musculus | Tbca | ENSMUSG00000042043 |
| rattus_norvegicus | Tbca | ENSRNOG00000048342 |
| drosophila_melanogaster | Tbca | FBGN0039869 |
| caenorhabditis_elegans | tbca-1 | WBGENE00021475 |
Protein
Protein identifiers
Tubulin-specific chaperone A — O75347 (reviewed: O75347)
Alternative names: TCP1-chaperonin cofactor A, Tubulin-folding cofactor A
All UniProt accessions (8): O75347, A0A494C144, E5RHG6, E5RIW3, E5RIX8, E5RJD8, E5RJM1, Q6FGD7
UniProt curated annotations — full annotation on UniProt →
Function. Tubulin-folding protein; involved in the early step of the tubulin folding pathway.
Subunit / interactions. Supercomplex made of cofactors A to E. Cofactors A and D function by capturing and stabilizing tubulin in a quasi-native conformation. Cofactor E binds to the cofactor D-tubulin complex; interaction with cofactor C then causes the release of tubulin polypeptides that are committed to the native state.
Subcellular location. Cytoplasm. Cytoskeleton.
Similarity. Belongs to the TBCA family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| O75347-1 | 1 | yes |
| O75347-2 | 2 |
RefSeq proteins (3): NP_001284667, NP_001284669, NP_004598* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR004226 | TBCA | Family |
| IPR036126 | TBCA_sf | Homologous_superfamily |
Pfam: PF02970
UniProt features (9 total): helix 5, initiator methionine 1, chain 1, modified residue 1, splice variant 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 1H7C | X-RAY DIFFRACTION | 1.8 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O75347-F1 | 94.29 | 0.94 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 2
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-389977 | Post-chaperonin tubulin folding pathway |
| R-HSA-391251 | Protein folding |
| R-HSA-392499 | Metabolism of proteins |
MSigDB gene sets: 187 (showing top):
MORF_MBD4, GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP, MORF_RAD21, KYNG_DNA_DAMAGE_DN, PUJANA_CHEK2_PCC_NETWORK, MORF_SKP1A, GOBP_PROTEIN_MATURATION, KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS, MORF_ATOX1, MORF_PPP6C, MORF_PPP2R4, GOBP_PROTEIN_FOLDING, SCHLOSSER_SERUM_RESPONSE_DN, KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP, SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
GO Biological Process (3): protein folding (GO:0006457), tubulin complex assembly (GO:0007021), post-chaperonin tubulin folding pathway (GO:0007023)
GO Molecular Function (5): RNA binding (GO:0003723), tubulin binding (GO:0015631), beta-tubulin binding (GO:0048487), protein-folding chaperone binding (GO:0051087), protein binding (GO:0005515)
GO Cellular Component (5): nucleolus (GO:0005730), cytoplasm (GO:0005737), microtubule (GO:0005874), microtubule cytoskeleton (GO:0015630), cytoskeleton (GO:0005856)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Protein folding | 1 |
| Metabolism of proteins | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular membraneless organelle | 2 |
| cellular process | 1 |
| protein maturation | 1 |
| protein-containing complex assembly | 1 |
| tubulin complex assembly | 1 |
| nucleic acid binding | 1 |
| cytoskeletal protein binding | 1 |
| tubulin binding | 1 |
| protein binding | 1 |
| binding | 1 |
| nuclear lumen | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| microtubule cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
| cytoskeleton | 1 |
Protein interactions and networks
STRING
1672 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TBCA | TBCC | Q15814 | 690 |
| TBCA | TUBA4A | P05215 | 676 |
| TBCA | TBCB | Q99426 | 667 |
| TBCA | TUBB2A | Q13885 | 617 |
| TBCA | TBCD | Q9BTW9 | 603 |
| TBCA | TUBB | P05218 | 562 |
| TBCA | A0A2R8Y809 | A0A2R8Y809 | 536 |
| TBCA | TBCE | Q15813 | 536 |
| TBCA | PFDN1 | O60925 | 517 |
| TBCA | TBCEL | Q5QJ74 | 512 |
| TBCA | TBC1D8B | Q0IIM8 | 440 |
| TBCA | ARL2 | P36404 | 436 |
| TBCA | PFDN2 | Q9UHV9 | 420 |
| TBCA | HTT | P42858 | 368 |
| TBCA | NARS2 | Q96I59 | 364 |
IntAct
42 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TBCA | psi-mi:“MI:0915”(physical association) | 0.590 | |
| TBCA | psi-mi:“MI:0915”(physical association) | 0.590 | |
| TERF2IP | TBCA | psi-mi:“MI:0915”(physical association) | 0.510 |
| ERBB3 | TBCA | psi-mi:“MI:0915”(physical association) | 0.370 |
| OTUB1 | EPM2A | psi-mi:“MI:0914”(association) | 0.350 |
| BCAR1 | PSMD11 | psi-mi:“MI:0914”(association) | 0.350 |
| BCAR1 | MYO1C | psi-mi:“MI:0914”(association) | 0.350 |
| STAT1 | KPNA6 | psi-mi:“MI:0914”(association) | 0.350 |
| SOD1 | NPEPPSL1 | psi-mi:“MI:0914”(association) | 0.350 |
| PRNP | CARNS1 | psi-mi:“MI:0914”(association) | 0.350 |
| PRNP | WDR91 | psi-mi:“MI:0914”(association) | 0.350 |
| CAV1 | ACOT7 | psi-mi:“MI:0914”(association) | 0.350 |
| TRIM24 | DDTL | psi-mi:“MI:0914”(association) | 0.350 |
| RIPK4 | TBCA | psi-mi:“MI:0914”(association) | 0.350 |
| TEK | LANCL1 | psi-mi:“MI:0914”(association) | 0.350 |
| MAPT | SHTN1 | psi-mi:“MI:0914”(association) | 0.350 |
| TUBB4B | TUBA1B | psi-mi:“MI:0914”(association) | 0.350 |
| TBCA | PLS1 | psi-mi:“MI:0914”(association) | 0.350 |
| VCP | SHTN1 | psi-mi:“MI:0914”(association) | 0.350 |
| VCP | FAM171A2 | psi-mi:“MI:0914”(association) | 0.350 |
| CASP3 | NACA | psi-mi:“MI:0914”(association) | 0.350 |
| GATA2 | EFCAB5 | psi-mi:“MI:0914”(association) | 0.350 |
| SMARCB1 | KIF2A | psi-mi:“MI:2364”(proximity) | 0.270 |
| SMARCB1 | FAM186A | psi-mi:“MI:2364”(proximity) | 0.270 |
| EPHA6 | ARHGAP32 | psi-mi:“MI:2364”(proximity) | 0.270 |
| CFTR | UBA6 | psi-mi:“MI:2364”(proximity) | 0.270 |
BioGRID (138): GDPGP1 (Co-fractionation), SEC31A (Co-fractionation), TBCA (Co-fractionation), TBCA (Co-fractionation), TBCA (Co-fractionation), TBCA (Co-fractionation), TBCA (Affinity Capture-MS), TBCA (Affinity Capture-MS), TBCA (Affinity Capture-RNA), TBCA (Affinity Capture-MS), FXN (Co-fractionation), LAP3 (Co-fractionation), LACTB2 (Co-fractionation), PMPCA (Co-fractionation), COA7 (Co-fractionation)
ESM2 similar proteins: A1A4P5, A1DGS2, A2R7Z2, B0BN18, O04350, O35685, O70591, O75347, O76031, P48427, P48428, P50502, P50503, P80584, Q07866, Q08851, Q08DB5, Q0VCY1, Q13190, Q15691, Q17QG2, Q3ZBD9, Q4SPU8, Q5D016, Q5R581, Q5R601, Q5R7N3, Q5R7Z5, Q5RF31, Q5U2U0, Q5ZLC7, Q5ZLF0, Q61166, Q63525, Q66HR2, Q66T82, Q68FJ8, Q6P848, Q6V291, Q8K1E0
Diamond homologs: O04350, O75347, P48427, P48428, P48606, P80584, P80585, Q6PEC1, Q75JC8, Q9Y703
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| TBCA | “up-regulates quantity by stabilization” | Tubulin | binding |
Disease & clinical
Clinical variants and AI predictions
ClinVar
14 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 11 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1405 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 5:77691494:TTTTC:T | acceptor_gain | 1.0000 |
| 5:77691495:TTTC:T | acceptor_gain | 1.0000 |
| 5:77691496:TTC:T | acceptor_gain | 1.0000 |
| 5:77691497:TC:T | acceptor_gain | 1.0000 |
| 5:77691498:CC:C | acceptor_gain | 1.0000 |
| 5:77691498:CCTAA:C | acceptor_loss | 1.0000 |
| 5:77691499:C:A | acceptor_loss | 1.0000 |
| 5:77691499:C:CC | acceptor_gain | 1.0000 |
| 5:77691500:T:A | acceptor_loss | 1.0000 |
| 5:77691504:A:AC | acceptor_gain | 1.0000 |
| 5:77693260:GCTTA:G | donor_loss | 1.0000 |
| 5:77693261:CTTA:C | donor_loss | 1.0000 |
| 5:77693262:TTA:T | donor_loss | 1.0000 |
| 5:77693263:TACTA:T | donor_loss | 1.0000 |
| 5:77693264:A:AC | donor_gain | 1.0000 |
| 5:77693264:A:T | donor_loss | 1.0000 |
| 5:77693265:C:CG | donor_gain | 1.0000 |
| 5:77693265:CT:C | donor_gain | 1.0000 |
| 5:77693265:CTA:C | donor_gain | 1.0000 |
| 5:77693265:CTAG:C | donor_gain | 1.0000 |
| 5:77693265:CTAGT:C | donor_gain | 1.0000 |
| 5:77708237:TTTAC:T | donor_loss | 1.0000 |
| 5:77708238:TTA:T | donor_loss | 1.0000 |
| 5:77708239:TACCT:T | donor_loss | 1.0000 |
| 5:77708240:A:T | donor_loss | 1.0000 |
| 5:77708241:CCTG:C | donor_gain | 1.0000 |
| 5:77708244:G:A | donor_gain | 1.0000 |
| 5:77708343:CCAAC:C | acceptor_gain | 1.0000 |
| 5:77708344:CAAC:C | acceptor_gain | 1.0000 |
| 5:77708344:CAACC:C | acceptor_gain | 1.0000 |
AlphaMissense
713 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 5:77693334:A:G | S60P | 0.995 |
| 5:77693279:A:G | L78P | 0.994 |
| 5:77693302:C:A | R70S | 0.994 |
| 5:77693302:C:G | R70S | 0.994 |
| 5:77693324:A:G | M63T | 0.994 |
| 5:77708313:C:G | A30P | 0.994 |
| 5:77693303:C:G | R70T | 0.993 |
| 5:77776205:C:G | R18P | 0.993 |
| 5:77708337:C:T | E22K | 0.992 |
| 5:77693303:C:A | R70M | 0.991 |
| 5:77693324:A:T | M63K | 0.991 |
| 5:77776226:A:C | I11S | 0.991 |
| 5:77776226:A:G | I11T | 0.991 |
| 5:77708336:T:A | E22V | 0.990 |
| 5:77693292:C:G | A74P | 0.989 |
| 5:77693342:A:G | L57P | 0.989 |
| 5:77708325:A:G | Y26H | 0.989 |
| 5:77693311:G:C | C67W | 0.988 |
| 5:77776237:T:A | R7S | 0.987 |
| 5:77776237:T:G | R7S | 0.987 |
| 5:77776211:A:T | V16E | 0.986 |
| 5:77776226:A:T | I11N | 0.986 |
| 5:77693324:A:C | M63R | 0.983 |
| 5:77693337:C:T | E59K | 0.983 |
| 5:77708336:T:G | E22A | 0.983 |
| 5:77776238:C:G | R7T | 0.981 |
| 5:77693313:A:G | C67R | 0.980 |
| 5:77693312:C:T | C67Y | 0.979 |
| 5:77708303:T:G | Q33P | 0.979 |
| 5:77691455:G:T | A97E | 0.978 |
dbSNP variants (sampled 300 via entrez): RS1000013429 (5:77754185 T>A,C), RS1000049539 (5:77705074 A>G), RS1000053839 (5:77725786 C>A), RS1000107723 (5:77738398 T>G), RS1000216783 (5:77777459 G>A), RS1000270452 (5:77733886 A>G), RS1000310659 (5:77698578 C>T), RS1000338434 (5:77702878 G>A,C,T), RS1000394883 (5:77691437 G>A), RS1000397896 (5:77696603 A>G), RS1000399349 (5:77777345 C>T), RS1000450998 (5:77735928 T>C), RS1000505439 (5:77731218 C>A,T), RS1000518055 (5:77758730 AG>A), RS1000537520 (5:77731511 A>T)
Disease associations
OMIM: gene MIM:610058 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
10 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004599_31 | Mean platelet volume | 2.000000e-10 |
| GCST010796_5447 | Electrocardiogram morphology (amplitude at temporal datapoints) | 3.000000e-08 |
| GCST010796_5448 | Electrocardiogram morphology (amplitude at temporal datapoints) | 5.000000e-08 |
| GCST010796_5449 | Electrocardiogram morphology (amplitude at temporal datapoints) | 1.000000e-08 |
| GCST90000025_43 | Appendicular lean mass | 1.000000e-10 |
| GCST90002395_452 | Mean platelet volume | 1.000000e-09 |
| GCST90002395_453 | Mean platelet volume | 6.000000e-13 |
| GCST90002401_164 | Platelet distribution width | 1.000000e-17 |
| GCST90002401_165 | Platelet distribution width | 1.000000e-27 |
| GCST90002402_774 | Platelet count | 1.000000e-13 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004327 | electrocardiography |
| EFO:0004980 | appendicular lean mass |
| EFO:0007984 | platelet component distribution width |
| EFO:0004309 | platelet count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL6066315 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
ChEMBL bioactivities
2 potent at pChembl≥5 of 2 total, top 2 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 8.04 | Kd | 9.129 | nM | CHEMBL5653589 |
| 8.04 | ED50 | 9.129 | nM | CHEMBL5653589 |
PubChem BioAssay actives
1 with measured affinity, of 2 total; 1 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.
| Compound | Assay | Type | Value | Unit |
|---|---|---|---|---|
| 4-methyl-3-[(2-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide | 2149552: Binding affinity to human TBCA incubated for 45 mins by Kinobead based pull down assay | kd | 0.0091 | uM |
CTD chemical–gene interactions
26 total (human), top 26 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | affects cotreatment, increases abundance, increases expression, decreases expression | 2 |
| triphenyl phosphate | affects expression | 1 |
| arsenite | increases reaction, affects binding | 1 |
| cobaltous chloride | increases expression | 1 |
| manganese chloride | affects cotreatment, increases abundance, increases expression | 1 |
| 3,4,3’,4’-tetrachlorobiphenyl | affects expression | 1 |
| microcystin RR | decreases expression | 1 |
| chloropicrin | affects expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| bisphenol S | increases expression | 1 |
| LDN 193189 | decreases expression, affects cotreatment | 1 |
| bisphenol AF | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Arsenic | affects cotreatment, increases abundance, increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Manganese | increases expression, affects cotreatment, increases abundance | 1 |
| Phenobarbital | affects expression | 1 |
| Theophylline | increases expression | 1 |
| Thiram | increases expression | 1 |
| Tobacco Smoke Pollution | affects expression | 1 |
| Tretinoin | decreases expression | 1 |
| Sodium Selenite | increases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
| beta-Naphthoflavone | increases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5652594 | Binding | Binding affinity to human TBCA incubated for 45 mins by Kinobead based pull down assay | NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.